Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901

Yasuyuki Takeda, Makoto Tanaka, Hiroyuki Miyazaki, Suguru Takeo, Kikuo Nomoto, Yasunobu Yoshikai

    Research output: Contribution to journalArticle

    16 Citations (Scopus)

    Abstract

    The growth of MethA tumor was significantly inhibited by oral administration of the α-glucan SPR-901 in BALB/c (+/+) mice but not in nude mice. Mice treated orally with SPR-901 exhibited an augmentation of antigen-specific resistance against rechallenge with the tumor cells. The tumor-neutralizing activity of regional lymph node cells from MethA-bearing mice against the tumor was augmented by oral administration of SPR-901. The tumor-neutralizing activity of lymph node cells from SPR-901-treated mice mainly appeared in Lyt2+cells. Furthermore, lymphokine-activated killer activity of these cells was enhanced by administration of SPR-901. The antitumor effect of SPR-901 was abrogated in mice depleted of either L3T4+ or Lyt2+ cells, and in cyclosporin-A-treated mice. These results suggest that Lyt2+ cells are important effector cells in MethA-bearing mice orally adminstered SPR-901 and that functional exertion of both Lyt2+ and L3T4+T cells is necessary for the antitumor effect of orally administered SPR-901 in vivo.

    Original languageEnglish
    Pages (from-to)143-148
    Number of pages6
    JournalCancer Immunology Immunotherapy
    Volume38
    Issue number3
    DOIs
    Publication statusPublished - May 1 1994

    Fingerprint

    Polysaccharides
    T-Lymphocytes
    Neoplasms
    Oral Administration
    Lymph Nodes
    Lymphokine-Activated Killer Cells
    Glucans
    rice bran saccharide
    Nude Mice
    Cyclosporine
    Antigens
    Growth

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology
    • Oncology
    • Cancer Research

    Cite this

    Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901. / Takeda, Yasuyuki; Tanaka, Makoto; Miyazaki, Hiroyuki; Takeo, Suguru; Nomoto, Kikuo; Yoshikai, Yasunobu.

    In: Cancer Immunology Immunotherapy, Vol. 38, No. 3, 01.05.1994, p. 143-148.

    Research output: Contribution to journalArticle

    Takeda, Yasuyuki ; Tanaka, Makoto ; Miyazaki, Hiroyuki ; Takeo, Suguru ; Nomoto, Kikuo ; Yoshikai, Yasunobu. / Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901. In: Cancer Immunology Immunotherapy. 1994 ; Vol. 38, No. 3. pp. 143-148.
    @article{bed35d5fb4be4aef8d21be64561c0b13,
    title = "Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901",
    abstract = "The growth of MethA tumor was significantly inhibited by oral administration of the α-glucan SPR-901 in BALB/c (+/+) mice but not in nude mice. Mice treated orally with SPR-901 exhibited an augmentation of antigen-specific resistance against rechallenge with the tumor cells. The tumor-neutralizing activity of regional lymph node cells from MethA-bearing mice against the tumor was augmented by oral administration of SPR-901. The tumor-neutralizing activity of lymph node cells from SPR-901-treated mice mainly appeared in Lyt2+cells. Furthermore, lymphokine-activated killer activity of these cells was enhanced by administration of SPR-901. The antitumor effect of SPR-901 was abrogated in mice depleted of either L3T4+ or Lyt2+ cells, and in cyclosporin-A-treated mice. These results suggest that Lyt2+ cells are important effector cells in MethA-bearing mice orally adminstered SPR-901 and that functional exertion of both Lyt2+ and L3T4+T cells is necessary for the antitumor effect of orally administered SPR-901 in vivo.",
    author = "Yasuyuki Takeda and Makoto Tanaka and Hiroyuki Miyazaki and Suguru Takeo and Kikuo Nomoto and Yasunobu Yoshikai",
    year = "1994",
    month = "5",
    day = "1",
    doi = "10.1007/BF01525634",
    language = "English",
    volume = "38",
    pages = "143--148",
    journal = "Cancer Immunology and Immunotherapy",
    issn = "0340-7004",
    publisher = "Springer Science and Business Media Deutschland GmbH",
    number = "3",

    }

    TY - JOUR

    T1 - Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901

    AU - Takeda, Yasuyuki

    AU - Tanaka, Makoto

    AU - Miyazaki, Hiroyuki

    AU - Takeo, Suguru

    AU - Nomoto, Kikuo

    AU - Yoshikai, Yasunobu

    PY - 1994/5/1

    Y1 - 1994/5/1

    N2 - The growth of MethA tumor was significantly inhibited by oral administration of the α-glucan SPR-901 in BALB/c (+/+) mice but not in nude mice. Mice treated orally with SPR-901 exhibited an augmentation of antigen-specific resistance against rechallenge with the tumor cells. The tumor-neutralizing activity of regional lymph node cells from MethA-bearing mice against the tumor was augmented by oral administration of SPR-901. The tumor-neutralizing activity of lymph node cells from SPR-901-treated mice mainly appeared in Lyt2+cells. Furthermore, lymphokine-activated killer activity of these cells was enhanced by administration of SPR-901. The antitumor effect of SPR-901 was abrogated in mice depleted of either L3T4+ or Lyt2+ cells, and in cyclosporin-A-treated mice. These results suggest that Lyt2+ cells are important effector cells in MethA-bearing mice orally adminstered SPR-901 and that functional exertion of both Lyt2+ and L3T4+T cells is necessary for the antitumor effect of orally administered SPR-901 in vivo.

    AB - The growth of MethA tumor was significantly inhibited by oral administration of the α-glucan SPR-901 in BALB/c (+/+) mice but not in nude mice. Mice treated orally with SPR-901 exhibited an augmentation of antigen-specific resistance against rechallenge with the tumor cells. The tumor-neutralizing activity of regional lymph node cells from MethA-bearing mice against the tumor was augmented by oral administration of SPR-901. The tumor-neutralizing activity of lymph node cells from SPR-901-treated mice mainly appeared in Lyt2+cells. Furthermore, lymphokine-activated killer activity of these cells was enhanced by administration of SPR-901. The antitumor effect of SPR-901 was abrogated in mice depleted of either L3T4+ or Lyt2+ cells, and in cyclosporin-A-treated mice. These results suggest that Lyt2+ cells are important effector cells in MethA-bearing mice orally adminstered SPR-901 and that functional exertion of both Lyt2+ and L3T4+T cells is necessary for the antitumor effect of orally administered SPR-901 in vivo.

    UR - http://www.scopus.com/inward/record.url?scp=0027957660&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0027957660&partnerID=8YFLogxK

    U2 - 10.1007/BF01525634

    DO - 10.1007/BF01525634

    M3 - Article

    C2 - 7907272

    AN - SCOPUS:0027957660

    VL - 38

    SP - 143

    EP - 148

    JO - Cancer Immunology and Immunotherapy

    JF - Cancer Immunology and Immunotherapy

    SN - 0340-7004

    IS - 3

    ER -